BioSpace News Archive

In today’s era of rising drug prices and health insurance costs, a growing number of United States healthcare consumers appear to be at a disadvantage when it comes to obtaining and staying on the treatment that’s best for them.

Biedermann Motech announced the further expansion of its product portfolio of advanced solutions for spinal surgery with the integration of the DELTA XS™ Shank Based Retractor System into its iMAS360™ Procedure as well as the launch of the MOSS VRS Pedicle Screw System, at the North American Spine Society Annual Meeting in Chicago, IL, September 25-27, 2019.

Body Vision Medical announced that it has closed $20 million in Series C funding.

89bio, Inc. (89bio or the company), a clinical-stage biopharmaceutical company, has initiated dosing in its proof of concept Phase 1b/2a clinical trial evaluating its product candidate, BIO89-100, in patients with nonalcoholic steatohepatitis (NASH) or patients with nonalcoholic fatty liver disease (NAFLD) and a high risk of NASH.

United Spinal Association played a key role in championing a resolution that passed the U.S. Senate designating September 2019 as National Spinal Cord Injury Awareness Month.

Today Inversago Pharma Inc., a preclinical-stage biotech company developing new CB1 blockers for the treatment of targeted metabolic disorders, announced the appointment of Dr. Caroline Fradette as Vice-President, Clinical Research.

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, provided an update on its commercialization plans for Renevia®, the Company’s facial aesthetics product, which was recently granted a Conformité Européenne (CE) Mark.

Hensler Surgical Technologies (HST), in partnership with Ohio native Foot & Ankle Surgeon, Peter Highlander, MD, today announced two new patent-pending Orthopedic applications.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra, will present at the 2019 Cantor Global Healthcare Conference.

Vitamin Angels, a global public health organization that connects undernourished mothers and children with essential vitamins and minerals, announced its $7.5M commitment to improve global maternal health and birth outcomes by 2022 at the Bill & Melinda Gates Foundation’s Goalkeepers event in New York City today.